Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FaSSIF-V3, but not compendial media, appropriately detects differences in the peak and extent of exposure between reference and test formulations of ibuprofen
Rodrigo Cristofoletti, Jennifer B. Dressman
European Journal of Pharmaceutics and Biopharmaceutics (2016) Vol. 105, pp. 134-140
Closed Access | Times Cited: 20

Showing 20 citing articles:

Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities
Bart Hens, Maura Corsetti, Robert E. Spiller, et al.
International Journal of Pharmaceutics (2016) Vol. 519, Iss. 1-2, pp. 79-97
Open Access | Times Cited: 93
Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption
Navpreet Kaur, Ajit S. Narang, Arvind K. Bansal
European Journal of Pharmaceutics and Biopharmaceutics (2018) Vol. 129, pp. 222-246
Closed Access | Times Cited: 71
A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP
Marival Bermejo, Bart Hens, Joseph Dickens, et al.
Pharmaceutics (2020) Vol. 12, Iss. 1, pp. 74-74
Open Access | Times Cited: 58
Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties
Deanna M. Mudie, Nasim Samiei, Derrick J. Marshall, et al.
The AAPS Journal (2020) Vol. 22, Iss. 2
Open Access | Times Cited: 58
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report
Xavier Pépin, Sumit Arora, Luiza Borges, et al.
Molecular Pharmaceutics (2024)
Open Access | Times Cited: 7
Measuring pH and Buffer Capacity in Fluids Aspirated from the Fasted Upper Gastrointestinal Tract of Healthy Adults
Chara Litou, Dimitrios Psachoulias, Maria Vertzoni, et al.
Pharmaceutical Research (2020) Vol. 37, Iss. 3
Closed Access | Times Cited: 33
Exploring in vitro solubility of lamotrigine in physiologically mimetic conditions to prospect the in vivo dissolution in pediatric population
Edilainy Rizzieri Caleffi, Fernanda Belincanta Borghi‐Pangoni, Julia Macente, et al.
Biopharmaceutics & Drug Disposition (2023) Vol. 44, Iss. 2, pp. 147-156
Closed Access | Times Cited: 7
The Discriminatory Power of the BCS-Based Biowaiver: A Retrospective With Focus on Essential Medicines
Martin A. Hofsäss, Jennifer B. Dressman
Journal of Pharmaceutical Sciences (2019) Vol. 108, Iss. 9, pp. 2824-2837
Closed Access | Times Cited: 22
Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen
Irene Camara-Martinez, Johannes Andreas Blechar, Alejandro Ruiz-Picazo, et al.
International Journal of Pharmaceutics (2021) Vol. 614, pp. 121415-121415
Open Access | Times Cited: 15
Using Physiologically Based Pharmacokinetic Modeling to Assess the Risks of Failing Bioequivalence Criteria: a Tale of Two Ibuprofen Products
Ioannis Loisios-Konstantinidis, Bart Hens, Amitava Mitra, et al.
The AAPS Journal (2020) Vol. 22, Iss. 5
Open Access | Times Cited: 16
Update on Gastrointestinal Biorelevant Media and Physiologically Relevant Dissolution Conditions
Daniela Amaral Silva, Neal M. Davies, Nádia Araci Bou‐Chacra, et al.
Dissolution Technologies (2022) Vol. 29, Iss. 2, pp. 62-75
Open Access | Times Cited: 9
Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers
Javier Reig-López, Marina Cuquerella-Gilabert, Enrique Bandín‐Vilar, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 199, pp. 114293-114293
Open Access | Times Cited: 1
Dissolution, phase behavior and mass transport of amorphous solid dispersions in aspirated human intestinal fluids
Ahmed Elkhabaz, Dana E. Moseson, Joachim Brouwers, et al.
Journal of Pharmaceutical Sciences (2024)
Closed Access | Times Cited: 1
In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound
Dawen Kou, Chen Zhang, Hiuwing Yiu, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 4, pp. 1607-1617
Closed Access | Times Cited: 12
The Introduction of a New Flexible In Vivo Predictive Dissolution Apparatus, GIS-Alpha (GIS-α), to Study Dissolution Profiles of BCS Class IIb Drugs, Dipyridamole and Ketoconazole
Yasuhiro Tsume, Sanjaykumar R. Patel, M. Wang, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 109, Iss. 11, pp. 3471-3479
Open Access | Times Cited: 11
In Vivo Predictive Dissolution and Simulation Workshop Report: Facilitating the Development of Oral Drug Formulation and the Prediction of Oral Bioperformance
Yasuhiro Tsume, Sanjaykumar R. Patel, Nikoletta Fotaki, et al.
The AAPS Journal (2018) Vol. 20, Iss. 6
Open Access | Times Cited: 10
Lowly-buffered biorelevant dissolution testing is not necessarily biopredictive of human bioequivalence study outcome: Relationship between dissolution and pharmacokinetics
Kazuki Matsui, Katsuki Nakamichi, Masatoshi Nakatani, et al.
International Journal of Pharmaceutics (2022) Vol. 631, pp. 122531-122531
Open Access | Times Cited: 6
Evaluation and prediction of oral drug absorption and bioequivalence with food-druginteraction
Yasuhiro Tsume
Drug Metabolism and Pharmacokinetics (2023) Vol. 50, pp. 100502-100502
Closed Access | Times Cited: 3
Compare and PASS − Fast screening of oral dosage forms for bioequivalence probability with the COMPASS software
Dorota Danielak, Daria Myslitska, Maciej Winiarski, et al.
International Journal of Pharmaceutics (2024), pp. 125123-125123
Closed Access
Physiologically based population pharmacokinetic/pharmacodynamic modeling and simulation approaches to support waivers of in vivo clinical pharmacology studies
Ioannis Loisios-Konstantinidis
(2022)
Closed Access
Page 1

Scroll to top